Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
Clinical trial NCT02696356 · COMPLETED
Trial details
- NCT number
- NCT02696356
- Sponsor
- BrightPath Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2018-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.